(Q46721837)

24 December 2017

title

Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy (English)

1 reference

24 December 2017

1 reference

0 references

J J Gagne

1

1 reference

24 December 2017

V Maio

series ordinal

2

1 reference

24 December 2017

C Rabinowitz

series ordinal

3

1 reference

24 December 2017

publication date

1 April 2008

1 reference

24 December 2017

Journal of Clinical Pharmacy and Therapeutics

published in

1 reference

24 December 2017

volume

33

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

141-151

1 reference

24 December 2017

Incidence and preventability of adverse drug events among older persons in the ambulatory setting

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Oral erythromycin and the risk of sudden death from cardiac causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Concomitant coumarin-NSAID therapy and risk for bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

A prospective study of the clarithromycin-digoxin interaction in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Drug-drug interactions among elderly patients hospitalized for drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Hospitalisations and emergency department visits due to drug-drug interactions: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Cerebral haemorrhage induced by warfarin - the influence of drug-drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Assessment of potential drug-drug interactions with a prescription claims database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Concordance of severity ratings provided in four drug interaction compendia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Possible international normalized ratio elevation associated with celecoxib and warfarin in an elderly psychiatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Adverse interaction between warfarin and indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Interaction of ibuprofen and warfarin on primary haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Check-List to Potential Clinically Important Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Interaction between fenofibrate and warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Fenofibrate and warfarin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Cimetidine Potentiation of the Hypoprothrombinemic Effect of Warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

The influence of quinolone derivatives on theophylline clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Interindividual variation and drug interactions with hormonal steroid contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Studying co-medication patterns: the impact of definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Potentially inappropriate medication prescribing for elderly outpatients in Emilia Romagna, Italy: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Utilization review of concomitant use of potentially interacting drugs in Thai patients using warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Co-dispensing of contraindicated medications in patients using cisapride in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co-medication in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Potential determinants of drug-drug interaction associated dispensing in community pharmacies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

Determinants of physicians' attitude towards prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00891.X

10.1111/J.1365-2710.2007.00891.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18315779

1 reference

24 December 2017